Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | S100A4 | P26447 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | PTPRC | P08575 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4612017 | 0.83 | PARP1 (0.53) | PARP1SMN1; SMN2S100A4KMT2AMEN1 | |
| SCHEMBL28914061 | 0.81 | PARP1 (0.47) | PARP1SMN1; SMN2S100A4KMT2AMEN1 | |
| SCHEMBL284027 | 0.80 | SMN1; SMN2 (0.61) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL30050991 | 0.80 | SMN1; SMN2 (0.61) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL14257644 | 0.80 | S100A4 (0.61) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| Methane SCHEMBL28163541 | 0.79 | SMN1; SMN2 (0.60) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL28012557 | 0.79 | SMN1; SMN2 (0.60) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL32674558 | 0.78 | S100A4 (0.53) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL31677721 | 0.78 | S100A4 (0.53) | SMN1; SMN2S100A4KMT2AMEN1POLB | |
| SCHEMBL4377088 | 0.78 | S100A4 (0.53) | SMN1; SMN2S100A4KMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9655550-B2 | Latent fingerprint detection method, heating evaporation device for detecting latent fingerprint, latent fingerprint detection apparatus, and composition for detecting latent fingerprint | EARTH CHEMICAL CO., LTD. (JP) | 2017-05-23 | — | — | US | claimed |
| US-20150245790-A1 | LATENT FINGERPRINT DETECTION METHOD, HEATING EVAPORATION DEVICE FOR DETECTING LATENT FINGERPRINT, LATENT FINGERPRINT DETECTION APPARATUS, AND COMPOSITION FOR DETECTING LATENT FINGERPRINT | TOAGOSEI, CO., LTD. (JP) | 2015-09-03 | — | — | US | claimed |
| EP-1539150-A4 | NAPHTHALIMIDE SYNTHESIS INCLUDING AMONAFIDE SYNTHESIS AND PHARMACEUTICAL PREPARATIONS THEREOF | CHEMGENEX PHARMACEUTICALS INC (US) | 2006-10-11 | — | — | EP | claimed |
| JP-2005533088-A | — | — | 2005-11-04 | — | — | JP | claimed |
| EP-1539150-A1 | NAPHTHALIMIDE SYNTHESIS INCLUDING AMONAFIDE SYNTHESIS AND PHARMACEUTICAL PREPARATIONS THEREOF | Chemgenex Pharmaceuticals Limited (US) | 2005-06-15 | — | — | EP | claimed |
| US-20040082788-A1 | Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof | CHEMGENEX THERAPEUTICS, INC. | 2004-04-29 | — | — | US | claimed |
| WO-2004004716-A1 | NAPHTHALIMIDE SYNTHESIS INCLUDING AMONAFIDE SYNTHESIS AND PHARMACEUTICAL PREPARATIONS THEREOF | CHEMGENEX PHARMACEUTICALS LIMITED (US) | 2004-01-15 | — | — | WO | claimed |
| CN-113666869-B | Naphthoimide dye containing amino group in supercritical CO 2 In (a) synthesis and dyeing method | 大连工业大学 | 2023-11-14 | — | — | CN | disclosed |
| CN-107847188-B | Composition for latent fingerprint detection | 东亚合成株式会社 | 2022-03-25 | — | — | CN | disclosed |
| CN-113666869-A | Naphthalimide dyes containing amino in supercritical CO2The synthesis and dyeing method of | 大连工业大学 | 2021-11-19 | — | — | CN | disclosed |
| EP-3329846-B1 | COMPOSITION FOR DETECTING LATENT FINGERPRINT | TOAGOSEI CO LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-20180368740-A1 | COMPOSITION FOR DETECTING LATENT FINGERPRINT | TOAGOSEI CO., LTD (JP) | 2018-12-27 | — | — | US | disclosed |
| EP-3329846-A1 | COMPOSITION FOR DETECTING LATENT FINGERPRINT | Toagosei Co., Ltd. (JP) | 2018-06-06 | — | — | EP | disclosed |
| EP-0283604-A2 | Process for fabricating a belt | XEROX CORPORATION (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0149914-B1 | OVERCOATED ELECTROPHOTOGRAPHIC IMAGING MEMBER | XEROX CORPORATION (US) | 1988-08-10 | — | — | EP | disclosed |
| US-4747992-A | SEAMLESS | XEROX CORPORATION | 1988-05-31 | — | — | US | disclosed |
| EP-0171262-A2 | Electrophotographic imaging member | XEROX CORPORATION (US) | 1986-02-12 | — | — | EP | disclosed |
| US-4557993-A | Process for preparing an electrophotographic imaging member with NiO interlayer | XEROX CORPORATION (US) | 1985-12-10 | — | — | US | disclosed |
| EP-0149914-A1 | Overcoated electrophotographic imaging member | XEROX CORPORATION (US) | 1985-07-31 | — | — | EP | disclosed |
| US-4515882-A | CHARGE TRANSFER COMPOUNDS AND CHARGE INJECTION ENABLING PARTICLES | XEROX CORPORATION (US) | 1985-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082788-A1 | Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof | NME4, MFN2, NDUFAB1 | PARP1 910/4885SMN1; SMN2 1313/4885S100A4 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.